Endometriosis research has evolved substantially in recent years, shedding light on its complex role in female reproductive health, particularly regarding ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

In patients with regional lymph node status 0-1, HER+ HER– early breast cancer (n = 2,290), 5-year invasive disease-free survival was 92.6% (95% CI, 90.8 to 94.0) with recurrence score (RS) 12-25 and ...

Surgery performed with its focus on one or more of the endocrine organs is referred to as endocrine surgery. The endocrine organs are glands located throughout the body, which secrete hormones that ...

The endocrine system is a control system of ductless glands that secrete chemical messengers called hormones that circulate within the body via the bloodstream to affect distant organs. Hormones act ...

Researchers have revealed a reason why endocrine resistance develops in breast cancers and how to potentially treat it in patients. Endocrine resistance -- a major cause of breast cancer deaths -- can ...

Multiple endocrine neoplasia type 1 (MEN1) is a genetic condition that causes tumors to form in endocrine glands and other organs. Despite not usually being cancerous, these tumors can be very ...

Long-term, low-level exposure to endocrine-disrupting chemicals costs the U.S. $340 billion in annual health care spending and lost wages, according to a study of epidemiological data (Lancet Diabetes ...

Endocrine disruptors are defined as substances, or mixtures of substances, that interfere with the function of the endocrine system. These chemicals can act at very low doses, often exert combined or ...

Once absorbed by the body, EDCs — doppelganger hormones — have free rein to decrease or increase normal hormone levels, or ...